NARATUXIMAB EMTANSINE
UNII WE1X5A83B9

Substance Identification & Data

This profile provides standardized clinical and technical data for Naratuximab Emtansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WE1X5A83B9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1607824-64-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WE1X5A83B9

CAS Registry Number

1607824-64-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NARATUXIMAB EMTANSINE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C100101

National Cancer Institute reference terminology for clinical and research data.

INN ID

10238

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Naratuximab Emtansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.